new BindingDB logo
myBDB logout

BDBM280851 3-{2-[4-amino-2-{6- chloro-1-[4- methylcyclohexylmethyl]- 1H-indazol-3-yl}-5- methyl-6-oxo-6,7- dihydro-5H-pyrrolo[2,3- d]pyrimidin-5-yl]-1,3- oxazol-4-yl}-2,2- dimethylpropanoic acid::US10030027, Example 132AA::US10030027, Example 132AB

SMILES: CC1CCC(Cn2nc(-c3nc4NC(=O)C(C)(c5nc(CC(C)(C)C(O)=O)co5)c4c(N)n3)c3ccc(Cl)cc23)CC1

InChI Key:

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 280851   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Guanylate cyclase soluble subunit alpha-1


(Homo sapiens (Human))
BDBM280851
PNG
(3-{2-[4-amino-2-{6- chloro-1-[4- methylcyclohexylm...)
Show SMILES CC1CCC(Cn2nc(-c3nc4NC(=O)C(C)(c5nc(CC(C)(C)C(O)=O)co5)c4c(N)n3)c3ccc(Cl)cc23)CC1 |(-1.39,-7.53,;-2.48,-6.44,;-3.97,-6.84,;-5.06,-5.75,;-4.66,-4.26,;-5.75,-3.17,;-5.35,-1.69,;-3.89,-1.21,;-3.89,.33,;-2.55,1.1,;-1.22,.33,;.11,1.1,;1.58,.62,;2.48,1.87,;4.02,1.87,;1.58,3.12,;.81,4.45,;2.91,3.89,;4.38,3.41,;5.28,4.66,;6.82,4.66,;7.59,5.99,;7.59,7.53,;6.26,6.76,;9.13,5.99,;9.9,7.32,;9.9,4.66,;4.38,5.9,;2.91,5.43,;.11,2.64,;-1.22,3.41,;-1.22,4.95,;-2.55,2.64,;-5.35,.81,;-5.98,2.21,;-7.51,2.37,;-8.41,1.13,;-9.9,1.53,;-7.79,-.28,;-6.26,-.44,;-3.17,-3.86,;-2.08,-4.95,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0740n/an/an/an/an/an/a7.4n/a



Merck Sharp & Dohme Corp.

US Patent




US Patent US10030027 (2018)


BindingDB Entry DOI: 10.7270/Q22N549C
More data for this
Ligand-Target Pair
Guanylate cyclase soluble subunit alpha-1


(Homo sapiens (Human))
BDBM280851
PNG
(3-{2-[4-amino-2-{6- chloro-1-[4- methylcyclohexylm...)
Show SMILES CC1CCC(Cn2nc(-c3nc4NC(=O)C(C)(c5nc(CC(C)(C)C(O)=O)co5)c4c(N)n3)c3ccc(Cl)cc23)CC1 |(-1.39,-7.53,;-2.48,-6.44,;-3.97,-6.84,;-5.06,-5.75,;-4.66,-4.26,;-5.75,-3.17,;-5.35,-1.69,;-3.89,-1.21,;-3.89,.33,;-2.55,1.1,;-1.22,.33,;.11,1.1,;1.58,.62,;2.48,1.87,;4.02,1.87,;1.58,3.12,;.81,4.45,;2.91,3.89,;4.38,3.41,;5.28,4.66,;6.82,4.66,;7.59,5.99,;7.59,7.53,;6.26,6.76,;9.13,5.99,;9.9,7.32,;9.9,4.66,;4.38,5.9,;2.91,5.43,;.11,2.64,;-1.22,3.41,;-1.22,4.95,;-2.55,2.64,;-5.35,.81,;-5.98,2.21,;-7.51,2.37,;-8.41,1.13,;-9.9,1.53,;-7.79,-.28,;-6.26,-.44,;-3.17,-3.86,;-2.08,-4.95,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.105n/an/an/an/an/an/a7.4n/a



Merck Sharp & Dohme Corp.

US Patent




US Patent US10030027 (2018)


BindingDB Entry DOI: 10.7270/Q22N549C
More data for this
Ligand-Target Pair